vs

Side-by-side financial comparison of Fastly, Inc. (FSLY) and MIMEDX GROUP, INC. (MDXG). Click either name above to swap in a different company.

Fastly, Inc. is the larger business by last-quarter revenue ($173.0M vs $118.1M, roughly 1.5× MIMEDX GROUP, INC.). MIMEDX GROUP, INC. runs the higher net margin — 12.9% vs -11.9%, a 24.7% gap on every dollar of revenue. On growth, MIMEDX GROUP, INC. posted the faster year-over-year revenue change (27.1% vs 19.8%). Over the past eight quarters, MIMEDX GROUP, INC.'s revenue compounded faster (18.1% CAGR vs 14.3%).

Fastly, Inc. is an American company based in San Francisco, which describes itself as a cloud computing company. Fastly provides content delivery network services, image optimization, and load balancing services. Fastly's cloud security services include denial-of-service attack protection, bot mitigation, and a web application firewall.

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

FSLY vs MDXG — Head-to-Head

Bigger by revenue
FSLY
FSLY
1.5× larger
FSLY
$173.0M
$118.1M
MDXG
Growing faster (revenue YoY)
MDXG
MDXG
+7.4% gap
MDXG
27.1%
19.8%
FSLY
Higher net margin
MDXG
MDXG
24.7% more per $
MDXG
12.9%
-11.9%
FSLY
Faster 2-yr revenue CAGR
MDXG
MDXG
Annualised
MDXG
18.1%
14.3%
FSLY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FSLY
FSLY
MDXG
MDXG
Revenue
$173.0M
$118.1M
Net Profit
$-20.5M
$15.2M
Gross Margin
62.5%
83.9%
Operating Margin
23.7%
17.8%
Net Margin
-11.9%
12.9%
Revenue YoY
19.8%
27.1%
Net Profit YoY
47.6%
104.2%
EPS (diluted)
$-0.13
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSLY
FSLY
MDXG
MDXG
Q1 26
$173.0M
Q4 25
$172.6M
$118.1M
Q3 25
$158.2M
$113.7M
Q2 25
$148.7M
$98.6M
Q1 25
$144.5M
$88.2M
Q4 24
$140.6M
$92.9M
Q3 24
$137.2M
$84.1M
Q2 24
$132.4M
$87.2M
Net Profit
FSLY
FSLY
MDXG
MDXG
Q1 26
$-20.5M
Q4 25
$-15.5M
$15.2M
Q3 25
$-29.5M
$16.7M
Q2 25
$-37.5M
$9.6M
Q1 25
$-39.1M
$7.0M
Q4 24
$-32.9M
$7.4M
Q3 24
$-38.0M
$8.1M
Q2 24
$-43.7M
$17.6M
Gross Margin
FSLY
FSLY
MDXG
MDXG
Q1 26
62.5%
Q4 25
61.4%
83.9%
Q3 25
58.4%
83.5%
Q2 25
54.5%
81.1%
Q1 25
53.2%
81.2%
Q4 24
53.4%
81.8%
Q3 24
54.5%
81.8%
Q2 24
55.1%
83.0%
Operating Margin
FSLY
FSLY
MDXG
MDXG
Q1 26
23.7%
Q4 25
-8.7%
17.8%
Q3 25
-18.2%
19.5%
Q2 25
-24.8%
12.5%
Q1 25
-26.4%
9.4%
Q4 24
-24.4%
11.9%
Q3 24
-29.6%
13.3%
Q2 24
-35.3%
26.9%
Net Margin
FSLY
FSLY
MDXG
MDXG
Q1 26
-11.9%
Q4 25
-9.0%
12.9%
Q3 25
-18.6%
14.7%
Q2 25
-25.2%
9.8%
Q1 25
-27.1%
8.0%
Q4 24
-23.4%
8.0%
Q3 24
-27.7%
9.6%
Q2 24
-33.0%
20.2%
EPS (diluted)
FSLY
FSLY
MDXG
MDXG
Q1 26
$-0.13
Q4 25
$-0.10
$0.10
Q3 25
$-0.20
$0.11
Q2 25
$-0.26
$0.06
Q1 25
$-0.27
$0.05
Q4 24
$-0.23
$0.05
Q3 24
$-0.27
$0.05
Q2 24
$-0.32
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSLY
FSLY
MDXG
MDXG
Cash + ST InvestmentsLiquidity on hand
$146.7M
$166.1M
Total DebtLower is stronger
$18.0M
Stockholders' EquityBook value
$977.1M
$256.5M
Total Assets
$1.5B
$342.7M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSLY
FSLY
MDXG
MDXG
Q1 26
$146.7M
Q4 25
$361.8M
$166.1M
Q3 25
$342.9M
$142.1M
Q2 25
$321.2M
$118.9M
Q1 25
$307.3M
$106.4M
Q4 24
$295.9M
$104.4M
Q3 24
$308.2M
$88.8M
Q2 24
$311.8M
$69.0M
Total Debt
FSLY
FSLY
MDXG
MDXG
Q1 26
Q4 25
$18.0M
Q3 25
Q2 25
Q1 25
Q4 24
$19.0M
Q3 24
Q2 24
Stockholders' Equity
FSLY
FSLY
MDXG
MDXG
Q1 26
$977.1M
Q4 25
$929.6M
$256.5M
Q3 25
$937.0M
$238.9M
Q2 25
$942.6M
$216.6M
Q1 25
$957.0M
$202.8M
Q4 24
$965.3M
$193.1M
Q3 24
$969.5M
$181.0M
Q2 24
$981.2M
$168.0M
Total Assets
FSLY
FSLY
MDXG
MDXG
Q1 26
$1.5B
Q4 25
$1.5B
$342.7M
Q3 25
$1.5B
$319.0M
Q2 25
$1.5B
$291.1M
Q1 25
$1.4B
$270.4M
Q4 24
$1.5B
$263.9M
Q3 24
$1.5B
$243.9M
Q2 24
$1.5B
$230.2M
Debt / Equity
FSLY
FSLY
MDXG
MDXG
Q1 26
Q4 25
0.07×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSLY
FSLY
MDXG
MDXG
Operating Cash FlowLast quarter
$28.9M
$25.0M
Free Cash FlowOCF − Capex
$4.1M
FCF MarginFCF / Revenue
2.4%
Capex IntensityCapex / Revenue
14.3%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters
$55.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSLY
FSLY
MDXG
MDXG
Q1 26
$28.9M
Q4 25
$22.4M
$25.0M
Q3 25
$28.9M
$29.3M
Q2 25
$25.8M
$14.4M
Q1 25
$17.3M
$5.3M
Q4 24
$5.2M
$18.8M
Q3 24
$5.0M
$19.6M
Q2 24
$-4.9M
$21.8M
Free Cash Flow
FSLY
FSLY
MDXG
MDXG
Q1 26
$4.1M
Q4 25
$12.2M
Q3 25
$22.9M
Q2 25
$15.9M
Q1 25
$14.7M
Q4 24
$251.0K
Q3 24
$3.0M
Q2 24
$-6.7M
FCF Margin
FSLY
FSLY
MDXG
MDXG
Q1 26
2.4%
Q4 25
7.1%
Q3 25
14.5%
Q2 25
10.7%
Q1 25
10.2%
Q4 24
0.2%
Q3 24
2.2%
Q2 24
-5.1%
Capex Intensity
FSLY
FSLY
MDXG
MDXG
Q1 26
14.3%
Q4 25
5.9%
Q3 25
3.8%
Q2 25
6.6%
Q1 25
1.8%
Q4 24
3.5%
Q3 24
1.5%
Q2 24
1.3%
Cash Conversion
FSLY
FSLY
MDXG
MDXG
Q1 26
Q4 25
1.64×
Q3 25
1.75×
Q2 25
1.50×
Q1 25
0.75×
Q4 24
2.53×
Q3 24
2.42×
Q2 24
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FSLY
FSLY

Network Services$126.2M73%
Security$38.8M22%
Other$8.0M5%

MDXG
MDXG

Wound$78.7M67%
Surgical$39.4M33%

Related Comparisons